GERMANTOWN, Md., June 21, 2018 /PRNewswire/ -- Senseonics Holdings, Inc. (NYSE American: SENS) today announced the U.S. Food and Drug Administration has approved its Premarket Approval (PMA) application to market
Growth Capitalist (https://growthcapitalist.com/2018/06/fda-approves-worlds-first-long-term-implantable-continuous-glucose-monitoring-system-for-marketing-in-united-states/)
GERMANTOWN, Md., June 21, 2018 /PRNewswire/ -- Senseonics Holdings, Inc. (NYSE American: SENS) today announced the U.S. Food and Drug Administration has approved its Premarket Approval (PMA) application to market